BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6238882)

  • 1. Investigations on platelet function in diabetes mellitus.
    Kubisz P; Arabi A; Holan J; Cronberg S
    Haemostasis; 1984; 14(4):347-53. PubMed ID: 6238882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B and platelet function in diabetes mellitus.
    Kubisz P; Parizek M; Cronberg S
    Haemostasis; 1986; 16(6):424-7. PubMed ID: 2953658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet arachidonic acid metabolism in diabetes mellitus.
    Halushka PV; Mayfield R; Wohltmann HJ; Rogers RC; Goldberg AK; McCoy SA; Loadholt CB; Colwell JA
    Diabetes; 1981; 30(Suppl 2):44-8. PubMed ID: 6795072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders.
    Smith IL; Martin TJ
    Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of insulin antibodies, platelet-fixing immune complexes and platelet-associated IgG to in vitro platelet aggregation and thromboxane B2 synthesis in childhood type 1 (insulin-dependent) diabetes mellitus.
    Triolo G; Davì G; Giardina E; Cardella F; Meli F; Strano A; Bompiani GD
    Diabetes Res; 1989 Jan; 10(1):1-5. PubMed ID: 2503285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and diabetic vascular disease.
    Paton RC; Passa P
    Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do platelets have anything to do with diabetic microvascular disease?
    Colwell JA; Winocour PD; Halushka PV
    Diabetes; 1983 May; 32 Suppl 2():14-9. PubMed ID: 6242836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet half-life in comparison to other in-vivo platelet function parameters such as thromboxane B2, beta-thromboglobulin and platelet factor 4 in patients with atherosclerotic lesions with and without hyperlipoproteinemia.
    Strobl-Jäger E; Fitscha P; Kaliman J; Widhalm K; Sinzinger H
    Vasa; 1986; 15(4):373-8. PubMed ID: 2948337
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin and arachidonic acid metabolism in diabetes mellitus.
    Halushka PV; Mayfield R; Colwell JA
    Metabolism; 1985 Dec; 34(12 Suppl 1):32-6. PubMed ID: 3934501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet adhesion and aggregation in diabetes mellitus.
    Colwell JA; Nair RM; Halushka PV; Rogers C; Whetsell A; Sagel J
    Metabolism; 1979 Apr; 28(4 Suppl 1):394-400. PubMed ID: 122293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vitamin E on platelet aggregation in diabetes mellitus.
    Watanabe J; Umeda F; Wakasugi H; Ibayashi H
    Thromb Haemost; 1984 Jul; 51(3):313-6. PubMed ID: 6495252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced platelet release reaction and increased thromboxane generation in esophageal achalasia and selective in vitro inhibition of arachidonic acid induced platelet aggregation by vasoactive intestinal peptide.
    Zahavi M; Rozen P; Zahavi J
    Thromb Res; 1990 Aug; 59(3):693-9. PubMed ID: 2146767
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
    Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased production of platelet thromboxane B2 in non-insulin-dependent diabetes. Relationship to vascular complications.
    D'Angelo A; Micossi P; Mannucci PM; Garimberti B; Franchi F; Pozza G
    Eur J Clin Invest; 1984 Apr; 14(2):83-6. PubMed ID: 6428908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of platelet reactivity in diabetes mellitus.
    Kutti J; Wadenvik H; Henestam B; Stenström G
    Acta Med Scand; 1986; 219(2):195-9. PubMed ID: 2938425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.